Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paroxetine versus trauma-focused CBT for PTSD
NL-OMON33037Phase 4Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of paroxetine in post-traumatic stress disorder (PTSD) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Change in PTSD symptoms and Cost-effectiveness based on PTSD improvement. Planned start Jun 2009; status: not yet recruiting.
02
Drugs
paroxetine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NL-OMON33037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33037.